Medical Biotechnology — Tech Evolutions

Entry	Year	Description	Impact
Medical Devices Rules, 2017	2017	These rules brought medical devices, including those incorporating biotechnological components, under a comprehensive regulatory framework in India, distinct from general drugs. They classify devices based on risk, mandate licensing, quality management systems, and post-market surveillance, ensuring safety and efficacy.	Significantly enhanced regulatory oversight for medical devices, promoting quality and patient safety. It streamlined the approval process for biotech-enabled devices while ensuring stringent standards, fostering both innovation and consumer protection in a rapidly growing sector.
National Guidelines for Gene Therapy Product Development and Clinical Trials (ICMR-DBT)	2019	These comprehensive guidelines, issued jointly by ICMR and DBT, provide a detailed framework for the development, manufacturing, and clinical trials of gene therapy products in India. They address ethical considerations, biosafety, and regulatory pathways, ensuring responsible research and clinical application.	Standardized the approach to gene therapy research and clinical trials, providing clarity for researchers and industry. It reinforces ethical principles, particularly regarding germline therapy prohibition, and aims to accelerate safe and effective gene therapy development in India, aligning with global best practices.